ÀüÈ«Àç
¾Ï¼¾ÅÍÀå
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : °£¾Ï/Ãé´ãµµ¾Ï
Á÷
ˤ
: ºÎ±³¼ö(¾Ï¼¾ÅÍÀå)
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
65
ÇØ¿Ü
Chon HJ*, Kim C*, Cho A, Kim YM, Jang SJ, Kim BO, Park CH, Hyung WJ, Ahn JB, Noh SH, Yun M, Rha SY. The Clinical Implications of FDG-PET/CT Differ According to Histology in Advanced Gastric Cancer. Gastric Cancer 2019 (IF 5.454)
64
ÇØ¿Ü
Kim C, Kim WR, Kim KY, Chon HJ, Beom SH, Kim H, Jung M, Shin SJ, Kim N, Ahn JB. Predictive Nomogram for Recurrence of Stage I Colorectal Cancer Following Curative Resection. Clinical Colorectal Cancer 2018 (IF 4.507);17(3):e513-e518.
63
ÇØ¿Ü
Kim HS, Chon HJ, Kim HK, Shin SJ, Wacheck Volker, Gruver AM, Kim JS, Rha SY, Chung HC. MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis. Journal of SUGGICAL ONCOLOGY 2018 (IF 2.886)
62
ÇØ¿Ü
Kim C*, Lee C*, Chon HJ*, Kim JH, Park HS, Heo SJ, Kim HJ, Kim TS, Kwon WS, Chung HC, Rha SY. PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer. Oncotarget 2017 (IF 5.168), 8(69):113494-501 (*Co-first author)
61
ÇØ¿Ü
Park HS, Park JS, Chun YJ, Roh YH, Moon J, Chon HJ, Choi HJ, Park JS, Lee DK, Lee SJ, Yoon, DS, Jeung HC. Prognostic factors and scoring model for survival in metastatic biliary tract cancer. Cancer Res Treat 2017 (IF 3.230)
60
ÇØ¿Ü
Chon HJ*, Hyung WJ*, Kim, C, Park SH, Kim JH, Park CH, Ahn JB, Kim HK, Chung HC, Rha SY, Noh SH, Jeung HC. Different implication of gastric signet ring cell carcinoma. Annals of Surgery 2017 (IF 9.203)
59
ÇØ¿Ü
Kim C, Yoo KH, Kim MH, Chon HJ, Lee SI, Koh S, Lee HY, Lee HR, Kim KS, Choi YD, Rha SY, Lee SJ, Kim HS. Different Subtypes of Epithelioid Sarcoma and Their Clinical Implication: Long-term Multi-Institutional Experience with a Rare Sarcoma. APMIS 2017 (IF 1.933), 125:223-229
58
ÇØ¿Ü
Kim C, Kim EK, Jung H, Chon HJ, Han JW, Shin KH, Hu H, Kim KS, Choi YD, Kim S, Lee YH, Suh JS, Ahn JB, Chung HC, Noh SH, Rha SYm Kim SH, Kim HS. Prognostic Implications of PD-L1 Expression in Patients with Soft Tissue Sarcoma. BMC Cancer 2016 (IF 3.265), 16:434
57
ÇØ¿Ü
Lim SM, Kim YN, Park KH, Kang BD, Chon HJ, Kim C, Kim JH, Rha SY. Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients. BMC Cancer 2016 (IF 3.265), 16:385
56
ÇØ¿Ü
Kim C, Yang H, Park I, Chon HJ, Kim JH, Kwon WS, Lee WS, Kim TS, Rha SY. Rho GTPase RhoJ is associated with gastric cancer progression and metastasis. Journal of Cancer 2016 (IF 3.609), 7(11):1550-1556
1
2
3
4
5
6
7
8
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729